Biomechanical lesions, not elsewhere classified

M13_BIOMECHLESIO

musculoskeletal system disease: A disease involving the musculoskeletal system. [database_cross_reference: MONDO:DesignPattern]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M99 Hospital discharge: ICD-9 — 739[0-9]\|7385 Cause of death: ICD-10 — M99 Cause of death: ICD-9 — 739[0-9]\|7385 2 out of 7 registries used, show all original rules.	1771
4. Check minimum number of events None	1771
5. Include endpoints None	1771
6. Filter based on genotype QC (FinnGen only)	1771

Control definitions (FinnGen only)

Control exclude: M13_MUSCULOSKELEOTH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M95-M99
Name in latin: Laesio biomechanica non alibi classificata

NAME	M13_BIOMECHLESIO
CONTROL_EXCLUDE	M13_MUSCULOSKELEOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M99
HD_ICD_9	739[0-9]\|7385
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M99
COD_ICD_9	739[0-9]\|7385
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Biomechanical lesions, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11514	6360	5079
Only index persons	9818	5551	4267
Unadjusted period prevalence (%)
Whole population	0.16	0.18	0.14
Only index persons	0.19	0.20	0.16
Median age at first event (years)
Whole population	53.30	53.79	52.53
Only index persons	50.54	51.17	49.72

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1771	1046	725
Unadjusted period prevalence (%)	0.34	0.36	0.32
Median age at first event (years)	53.53	50.48	57.93

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1548: Matched controls
15481

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

3054.1

285.3

267

M99.6

ICD-10 Finland

Osseous and subluxation stenosis of intervertebral foramina

611.8

266.7

257

7396A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Lower extremities

+∞

238.9

223

M48.0

ICD-10 Finland

Spinal stenosis

7.1

179.5

508

996

M99.8

ICD-10 Finland

Other biomechanical lesions

1736.8

160.2

153

M99.5

ICD-10 Finland

Intervertebral disc stenosis of neural canal

473.5

133.2

131

M99.0

ICD-10 Finland

Segmental and somatic dysfunction

1357.3

130.1

125

M99.9

ICD-10 Finland

Biomechanical lesion, unspecified

445.7

125.7

124

N03AX16

ATC

pregabalin; oral

3.9

113.5

619

2277

N02AX02

ATC

tramadol; systemic, rectal

3.2

103.8

908

4717

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

6.9

98.1

264

445

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

5.2

91.7

320

742

N03AX12

ATC

gabapentin; oral

3.9

88.5

435

1408

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

7.6

88.0

219

327

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

4.1

87.6

405

1240

M54.4

ICD-10 Finland

Lumbago with sciatica

3.8

83.0

426

1420

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.6

73.6

285

725

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.9

70.7

338

1044

7397A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Upper extremities

+∞

67.2

M54.5

ICD-10 Finland

Low back pain

2.7

65.9

651

3311

M79.6

ICD-10 Finland

Pain in limb

2.5

59.0

675

3663

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.3

54.6

221

577

L03

ICPC

Low back symptom/complaint

2.6

52.4

482

2285

7385A

ICD-9 Finland

Other acquired deformity of back or spine

+∞

51.3

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

9.1

51.2

111

130

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.2

49.8

819

5173

R4110

NOMESCO Finland

Physiotherapy

2.4

46.8

515

2657

M43.1

ICD-10 Finland

Spondylolisthesis

6.0

46.2

133

237

N02AJ06

ATC

codeine and paracetamol; systemic

2.2

45.2

670

3974

1220

FHL

Arthroscopy

5.4

43.4

138

277

M01AH05

ATC

etoricoxib; oral

2.0

39.3

957

6843

L28

ICPC

Limited function/disability (L)

2.6

37.5

314

1371

M03BX02

ATC

tizanidine; oral

2.0

37.4

1005

7398

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

6.0

37.1

106

187

M01AB05

ATC

diclofenac; systemic, rectal

2.0

36.9

1067

8063

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.9

35.6

122

266

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.9

34.3

232

886

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.8

33.8

154

441

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.1

33.7

137

354

A02BC02

ATC

pantoprazole; systemic

2.0

33.5

1046

7971

M54.1

ICD-10 Finland

Radiculopathy

4.7

33.3

117

262

N06AX21

ATC

duloxetine; oral

2.9

33.1

229

887

M03BC01

ATC

orphenadrine (citrate); systemic

2.2

32.5

422

2280

L86

ICPC

Back syndrome with radiating pain

3.7

31.9

147

424

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

31.1

296

1375

M54.3

ICD-10 Finland

Sciatica

3.6

30.0

145

435

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

29.6

639

4191

N02BE01

ATC

paracetamol; systemic, rectal

2.2

29.4

1342

11504

7392A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Thoracic region

+∞

29.3

N06AA09

ATC

amitriptyline; systemic

2.8

29.2

211

837

M01AH01

ATC

celecoxib; oral (coxibs)

2.2

29.0

341

1748

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

28.0

328

1677

WX402

NOMESCO Finland

General anaesthesia

2.3

28.0

303

1492

M25.5

ICD-10 Finland

Pain in joint

2.0

27.9

470

2793

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

7.5

27.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

27.3

577

3723

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.7

27.2

210

865

M99.4

ICD-10 Finland

Connective tissue stenosis of neural canal

+∞

27.2

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

27.0

455

2701

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.6

26.9

223

WX110

NOMESCO Finland

Local anesthesy

1.8

26.8

1043

8220

R06.0

ICD-10 Finland

Dyspnoea

2.0

26.5

416

2399

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

264.8

25.8

M01AE02

ATC

naproxen; oral, rectal

1.8

25.6

869

6500

L17

ICPC

Foot/toe symptom/complaint

2.0

24.9

410

2399

M70.6

ICD-10 Finland

Trochanteric bursitis

2.4

24.9

223

995

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.7

24.1

111

320

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.5

24.0

197

839

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

22.6

455

2847

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

22.4

389

2306

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

22.3

430

2648

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

22.0

234

1133

7395A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Pelvic region

+∞

21.9

M99.7

ICD-10 Finland

Connective tissue and disc stenosis of intervertebral foramina

116.7

21.6

R03AC02

ATC

salbutamol; inhalant

1.7

21.2

798

6011

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.9

21.1

233

M54.2

ICD-10 Finland

Cervicalgia

2.8

21.0

142

536

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.8

21.0

255

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

5.1

20.8

137

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

20.8

397

2423

M01AC06

ATC

meloxicam; systemic, rectal

1.7

20.8

571

3919

A02BC05

ATC

esomeprazole; systemic

1.7

20.2

630

4480

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.0

20.0

214

M79.1

ICD-10 Finland

Myalgia

2.2

19.8

215

1048

7393A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Lumbar region

+∞

19.8

R52.2

ICD-10 Finland

Other chronic pain

4.0

19.7

212

ZXA05

NOMESCO Finland

Left side

1.8

19.6

410

2577

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

19.6

466

3051

B01AB05

ATC

enoxaparin; parenteral

1.7

19.5

486

3221

S18

ICPC

Laceration/cut

1.7

19.3

627

4489

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

19.3

337

1987

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

6.3

19.2

L02

ICPC

Back symptom/complaint

2.5

18.9

153

641

M01AX17

ATC

nimesulide; oral

1.8

18.9

398

2501

N06AX16

ATC

venlafaxine; oral

2.1

18.9

228

1166

A01

ICPC

Pain general/multiple sites

2.6

18.7

140

564

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

24.0

18.7

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

18.6

1022

8392

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.4

18.3

164

728

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.8

18.3

123

464

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.8

18.2

119

441

M54

ICD-10 Finland

Dorsalgia

2.2

18.2

197

956

A02BC01

ATC

omeprazole; systemic

1.7

18.1

443

2912

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

8.5

18.0

M02AA07

ATC

piroxicam; topical

1.7

18.0

571

4043

M50.3

ICD-10 Finland

Other cervical disc degeneration

4.8

17.9

129

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.3

17.8

9183

FHL

Posterolateral spondylodesis

67.4

17.7

L08

ICPC

Shoulder symptom/complaint

1.9

17.7

298

1733

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

17.6

325

1947

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

7.3

17.6

L12

ICPC

Hand/finger symptom/complaint

2.1

17.4

219

1134

J01AA02

ATC

doxycycline; systemic

1.7

17.4

1179

10137

J01DB01

ATC

cefalexin; oral

1.7

17.3

1225

10656

N05CF01

ATC

zopiclone; oral

1.7

17.2

500

3442

ZXA00

NOMESCO Finland

Right side

1.7

17.2

428

2819

WX320

NOMESCO Finland

Spinalanesthesy

1.8

16.9

355

2220

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

16.8

448

3007

UJF32

NOMESCO Finland

Coloscopy

1.7

16.8

403

2623

QBJ30

NOMESCO Finland

Correction of abdominal apron

8.9

16.7

7399X

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Abdomen and other

+∞

16.7

G44.2

ICD-10 Finland

Tension-type headache

2.1

16.6

214

1120

M01AH02

ATC

rofecoxib; oral

2.0

16.6

229

1229

M99.1

ICD-10 Finland

Subluxation complex (vertebral)

91.0

16.6

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

11.7

16.5

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

16.5

910

7355

M01AB55

ATC

diclofenac, combinations; oral

2.5

16.4

136

579

N06AX11

ATC

mirtazapine; oral

1.7

16.4

475

3256

N02AC04

ATC

dextropropoxyphene; oral

3.2

16.3

282

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

12.9

16.2

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.4

16.1

241

A28

ICPC

Limited function/disability NOS

1.9

15.8

236

1309

J01FA06

ATC

roxithromycin; oral

1.6

15.7

619

4592

7384A

ICD-9 Finland

Other acquired deformity, Acquired spondylolisthesis

+∞

15.6

M01AE01

ATC

ibuprofen; systemic, rectal

1.8

15.6

1331

11966

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.3

15.6

242

R53

ICD-10 Finland

Malaise and fatigue

1.8

15.5

317

1956

H02AB06

ATC

prednisolone; systemic

1.6

15.4

702

5380

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

15.4

263

1530

A02BC03

ATC

lansoprazole; oral

1.6

15.4

453

3111

N01

ICPC

Headache

2.3

15.3

145

660

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

6.8

15.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

14.9

726

5641

N05BA01

ATC

diazepam; systemic, rectal

1.9

14.7

222

1231

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.9

14.7

163

M79.7

ICD-10 Finland

Fibromyalgia

3.5

14.6

205

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.9

14.6

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

14.4

112

461

N05BA04

ATC

oxazepam; oral

1.7

14.4

373

2465

A02BA02

ATC

ranitidine; systemic

1.8

14.4

309

1930

R4120

NOMESCO Finland

Occupational therapy

2.5

14.4

117

494

M54.6

ICD-10 Finland

Pain in thoracic spine

2.6

14.3

108

439

R42

ICD-10 Finland

Dizziness and giddiness

1.7

14.2

336

2164

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

14.2

197

1058

M54.8

ICD-10 Finland

Other dorsalgia

3.2

14.1

249

R52.9

ICD-10 Finland

Pain, unspecified

2.3

14.1

135

619

L13

ICPC

Hip symptom/complaint

1.9

14.0

238

1377

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

14.0

641

4887

Z71.8

ICD-10 Finland

Other specified counselling

1.7

13.9

329

2116

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.4

13.8

209

R02

ICPC

Shortness of breath/dyspnoea

2.0

13.8

198

1079

D01

ICPC

Abdominal pain/cramps general

2.1

13.7

162

818

M43.0

ICD-10 Finland

Spondylolysis

4.5

13.6

106

A06AD11

ATC

lactulose; oral

1.9

13.6

224

1285

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

13.5

785

6294

L84

ICPC

Back syndrome without radiat pain

3.0

13.4

270

S29

ICPC

Skin symptom/complaint other

1.8

13.2

248

1485

ACC51

NOMESCO Finland

Release of median nerve

2.3

13.1

122

550

L01

ICPC

Neck symptom/complaint

1.9

13.0

205

1153

L15

ICPC

Knee symptom/complaint

1.7

12.9

300

1913

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

12.8

675

5274

N02AA05

ATC

oxycodone; systemic

1.8

12.7

220

1278

J01DA01

ATC

[U] cefalexin; systemic

1.5

12.6

923

7717

K30

ICD-10 Finland

Functional dyspepsia

2.0

12.6

170

903

WX002

NOMESCO Finland

Sedation and analgesia

1.7

12.6

303

1952

N03AE01

ATC

clonazepam; systemic

2.4

12.6

106

457

M99.2

ICD-10 Finland

Subluxation stenosis of neural canal

+∞

12.5

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.3

12.4

112

498

K02.1

ICD-10 Finland

Caries of dentine

1.5

12.3

782

6334

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

11.7

12.3

J01MA02

ATC

ciprofloxacin; systemic

1.5

12.3

550

4138

J01FF01

ATC

clindamycin; systemic

1.6

12.2

401

2804

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.4

12.2

101

432

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.3

12.2

191

R07.3

ICD-10 Finland

Other chest pain

2.1

12.1

144

726

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

12.0

738

5924

R51.80

ICD-10 Finland

Headache

1.8

12.0

207

1200

L14

ICPC

Leg/thigh symptom/complaint

2.2

11.9

122

575

J01EA01

ATC

trimethoprim; systemic

1.6

11.9

373

2573

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

11.9

593

4556

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

11.9

127

614

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

3.1

11.8

218

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

11.7

135

674

J02AC01

ATC

fluconazole; systemic

1.5

11.7

565

4309

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

11.7

176

974

M53.2

ICD-10 Finland

Spinal instabilities

7.8

11.6

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

11.6

307

2026

R60.0

ICD-10 Finland

Localized oedema

1.9

11.6

170

933

N06AB03

ATC

fluoxetine; oral

1.9

11.6

188

1070

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

11.5

122

586

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

11.5

309

2049

S21

ICPC

Skin texture symptom/complaint

1.9

11.5

184

1042

7391A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Cervical region

+∞

11.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

11.5

239

1472

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.9

11.4

167

915

79199

ICD-8 Finland

Headache

6.1

11.4

UJD02

NOMESCO Finland

Gastroscopy

2.6

11.3

342

AA1AD

NOMESCO Finland

CT of head and brain

1.6

11.3

345

2363

X58

ICD-10 Finland

Exposure to other specified factors

1.8

11.3

202

1187

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

11.3

127

626

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

11.3

415

2970

C07AB07

ATC

bisoprolol; oral

1.5

11.2

669

5312

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

11.1

203

1203

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

10.9

157

855

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

10.9

562

4331

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.7

10.7

123

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

10.7

232

1444

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

10.7

299

1997

M03BX01

ATC

baclofen; systemic

4.1

10.6

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.8

10.6

240

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

3.6

10.6

135

WX704

NOMESCO Finland

Intubation

2.2

10.5

112

539

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

7.4

10.5

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.2

10.5

112

541

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.2

10.4

110

529

7394A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Sacral region

+∞

10.4

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

10.4

788

6520

WX200

NOMESCO Finland

Interscalenous plexus blockade

4.1

10.2

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.1

10.2

SPAT1336

SPAT

Request for examination

2.6

10.1

277

G04BD12

ATC

mirabegron; oral

1.9

10.1

147

805

M01AX05

ATC

glucosamine; oral

1.6

10.0

294

1986

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.8

9.9

169

974

K59.0

ICD-10 Finland

Constipation

2.3

9.9

431

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.2

9.9

443

G47.3

ICD-10 Finland

Sleep apnoea

1.6

9.9

291

1969

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

9.9

256

1676

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

9.8

161

918

J01CA04

ATC

amoxicillin; systemic

1.5

9.8

1150

10275

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

9.8

123

638

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

7.4

9.7

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

9.7

289

1961

J01FA09

ATC

clarithromycin; systemic

1.5

9.7

438

3269

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.3

9.6

381

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

9.6

123

640

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.0

9.6

127

669

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

9.6

219

9211

FHL

Exploration or removal of diskusprolapse

3.6

9.6

120

N06AB10

ATC

escitalopram; oral

1.6

9.6

272

1824

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.9

9.5

191

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

9.5

263

1751

R03BA02

ATC

budesonide; inhalant

1.6

9.5

246

1610

Z01.2

ICD-10 Finland

Dental examination

1.4

9.4

553

4336

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

9.4

412

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

9.4

102

496

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

9.4

317

2213

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

9.4

242

1580

R01AD09

ATC

mometasone; nasal

1.4

9.3

607

4850

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.3

9.3

382

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.7

9.3

242

M15

ICD-10 Finland

Polyarthrosis

2.4

9.3

343

EB1AA

SPAT

2.5

9.3

293

M47.8

ICD-10 Finland

Other spondylosis

9.6

9.3

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

9.6

9.3

M01AX01

ATC

nabumetone; oral

2.4

9.3

344

N17

ICPC

Vertigo/dizziness

1.8

9.2

160

931

W19

ICD-10 Finland

Unspecified fall

1.9

9.2

132

717

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.1

9.2

101

495

A02BA04

ATC

nizatidine; systemic

2.0

9.1

121

640

R96

ICPC

Asthma

1.9

9.1

129

700

N03AX09

ATC

lamotrigine; oral

2.5

9.0

277

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.4

9.0

337

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.1

9.0

160

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

8.9

198

1238

G04CA02

ATC

tamsulosin; oral

1.5

8.9

290

2004

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

8.9

103

515

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

3.8

8.8

A11

ICPC

Chest pain NOS

2.0

8.8

111

575

N05CF02

ATC

zolpidem; oral

1.6

8.8

245

1629

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

8.8

151

876

A04

ICPC

Weakness/tiredness general

1.7

8.8

179

1094

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

8.7

387

2864

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.2

8.7

424

XF404

NOMESCO Finland

Ambulatory ECG

1.9

8.7

130

718

L05

ICPC

Flank/axilla symptom/complaint

2.3

8.7

337

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

4.5

8.7

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

8.6

546

4325

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.6

8.6

248

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

8.5

109

567

M19.8

ICD-10 Finland

Other specified arthrosis

2.6

8.5

231

U02

ICPC

Urinary frequency/urgency

1.7

8.5

180

1115

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

90.5

8.4

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.7

8.4

220

UJH02

NOMESCO Finland

Anoscopy

2.4

8.4

283

P01AB01

ATC

metronidazole; oral, rectal

1.4

8.4

547

4354

J01FA10

ATC

azithromycin; systemic

1.4

8.3

768

6473

N06AA10

ATC

nortriptyline; systemic

3.2

8.3

135

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

8.3

441

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.8

8.2

137

783

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

8.2

447

3437

R06AX27

ATC

desloratadine; oral

1.5

8.2

346

2527

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

4.3

8.2

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.7

8.2

169

1036

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

3.8

8.2

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

4.4

8.1

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

8.1

155

928

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

8.1

333

2424

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.4

8.1

295

R35

ICD-10 Finland

Polyuria

2.1

8.0

467

S22.3

ICD-10 Finland

Fracture of rib

2.0

8.0

481

R05

ICPC

Cough

1.5

8.0

294

2087

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.6

8.0

231

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

8.0

238

1607

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

8.0

122

678

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

4.0

8.0

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

7.9

311

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

7.9

106

565

XKD00

NOMESCO Finland

Uroflowmetry

1.6

7.8

209

1374

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

7.8

445

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.3

7.8

114

P03

ICPC

Feeling depressed

1.9

7.8

111

603

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.2

7.8

340

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

7.8

160

980

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

3.2

7.7

120

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

7.7

538

4312

K04.0

ICD-10 Finland

Pulpitis

1.8

7.7

122

688

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.0

7.7

467

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

7.7

271

1907

R5110

SPAT

2.9

7.7

160

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

7.7

153

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

7.7

161

994

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

7.6

247

1703

D06

ICPC

Abdominal pain localized other

1.9

7.6

112

616

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.5

7.6

245

N02AA03

ATC

hydromorphone; systemic, rectal

18.4

7.6

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

11.9

7.6

A03FA02

ATC

cisapride; oral, rectal

1.8

7.6

119

670

KMAK

NOMESCO Finland

1.4

7.6

690

5775

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

7.5

236

1614

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

7.5

389

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

7.5

376

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

7.5

582

4742

R21

ICPC

Throat symptom/complaint

1.5

7.4

235

1612

L29

ICPC

Musculoskeletal sympt/complt other

1.9

7.4

108

590

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

6.5

7.4

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

7.4

243

1680

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

7.7

7.4

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

7.4

132

777

TQW40

SPAT

2.6

7.4

199

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

7.3

352

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.0

7.3

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

7.3

485

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.7

7.2

142

856

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

7.2

473

C05AA08

ATC

fluocortolone; rectal, topical

1.6

7.2

204

1361

G54.0

ICD-10 Finland

Brachial plexus disorders

2.9

7.2

149

M02AA10

ATC

ketoprofen; topical

1.5

7.2

221

1506

C08CA01

ATC

amlodipine; oral

1.4

7.2

483

3840

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.9

7.2

142

N30.0

ICD-10 Finland

Acute cystitis

1.6

7.2

181

1175

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.8

7.1

124

720

WX290

NOMESCO Finland

Other blockade of nerve

1.4

7.1

563

4593

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.1

7.1

351

R12

ICD-10 Finland

Heartburn

1.9

7.1

499

G04BD08

ATC

solifenacin; oral

1.9

7.1

529

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

7.1

306

2243

XA402

NOMESCO Finland

ENMG

2.8

7.0

152

R51

ICD-10 Finland

Headache

2.1

7.0

358

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

7.0

103

567

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

4.0

7.0

N05AH04

ATC

quetiapine; oral

1.5

7.0

214

1456

E0000UV

ATC

1.4

7.0

520

4202

N05BB01

ATC

hydroxyzine; systemic

2.0

6.9

468

N05AA02

ATC

levomepromazine; systemic

2.3

6.9

273

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

4.6

6.9

D09

ICPC

Nausea

2.4

6.9

234

L09

ICPC

Arm symptom/complaint

2.4

6.9

242

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.2

6.9

109

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

6.9

137

833

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

8.3

6.8

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

6.8

383

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

6.8

132

797

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.6

6.8

191

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.7

6.8

156

7225B

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]

11.0

6.8

-1

NOMESCO Finland

1.4

6.8

417

3262

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

16.8

6.7

SPAT1342

SPAT

Referral to specialised care

4.3

6.7

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

6.7

108

612

M23.8

ICD-10 Finland

Other internal derangements of knee

2.4

6.7

231

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

6.7

790

6827

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.7

6.7

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

6.7

519

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.3

6.7

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

6.7

167

1083

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

6.6

143

887

XF402

NOMESCO Finland

ECG with work load test

1.6

6.6

154

977

ZXA10

NOMESCO Finland

Bilateral

1.5

6.6

249

1774

A08

ICPC

Swelling

2.3

6.6

277

D07AC01

ATC

betamethasone; topical

1.4

6.6

463

3697

M35.7

ICD-10 Finland

Hypermobility syndrome

4.6

6.6

ZZH40

NOMESCO Finland

Substitute of bone

4.0

6.6

S06.0

ICD-10 Finland

Concussion

1.7

6.6

136

834

N02BE51

ATC

paracetamol, combinations excl. psycholeptics; systemic

3.9

6.6

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.6

6.5

172

UKC02

NOMESCO Finland

Cystoscopy

1.5

6.5

208

1427

R03AC03

ATC

terbutaline; inhalant

1.6

6.5

185

1236

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

6.5

182

1211

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

3.6

6.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

6.5

262

1890

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

6.5

143

893

U07

ICPC

Urine symptom/complaint other

2.0

6.5

421

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

6.5

450

QAE99

SPAT

5.7

6.5

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

5.7

6.5

C07AA05

ATC

propranolol; systemic

1.5

6.4

248

1772

NF1DA

NOMESCO Finland

X-ray of hips

3.0

6.4

115

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

3.5

6.4

R33

ICD-10 Finland

Retention of urine

1.8

6.4

107

615

1225

FHL

Arthroscopy and other therapeutic procedure

3.3

6.4

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

6.3

358

2750

C03CA01

ATC

furosemide; systemic

1.4

6.3

375

2906

WX110

SPAT

2.2

6.3

279

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.1

6.3

314

L60.0

ICD-10 Finland

Ingrowing nail

2.2

6.3

280

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.9

6.3

125

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

11.1

6.3

A97

ICPC

No disease

1.5

6.3

188

1270

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

6.3

239

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.4

6.3

200

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

6.3

141

885

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

6.3

138

864

P06

ICPC

Sleep disturbance

1.7

6.3

123

743

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

6.2

111

652

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.2

6.2

D12

ICPC

Constipation

2.4

6.2

221

G99.2*M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

26.8

6.2

E000001

ATC

1.4

6.2

268

1960

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

3.5

6.2

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

6.2

200

1375

R52.0

ICD-10 Finland

Acute pain

2.5

6.2

184

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.4

6.2

214

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.3

6.1

235

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

6.1

338

2587

R01AD08

ATC

fluticasone; nasal

1.4

6.1

367

2848

N05CD07

ATC

temazepam; oral

1.6

6.1

173

1152

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

6.1

544

M50

ICD-10 Finland

Cervical disc disorders

4.7

6.1

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.1

115

689

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

6.1

487

3958

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

10.1

6.0

M41.2

ICD-10 Finland

Other idiopathic scoliosis

10.1

6.0

R05

ICD-10 Finland

Cough

1.4

6.0

255

1857

R06AE07

ATC

cetirizine; oral

1.3

6.0

568

4730

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.1

6.0

321

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3033658) Prothrombin time (PT) actual/Normal

640

3685

2.15

48.65

4.7

3.8

91.3

90.1

0.56

629

3585

(36304419) Bacteria [Presence] in Urine

650

3949

2.02

41.28

3.8

3.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

433

2311

2.16

38.56

3.7

2.9

e6/l

3.5

2.7

0.67

199

1273

(3018095) Leukocytes [#/volume] in Urine

785

5178

1.93

38.53

4.6

3.7

e6/l

61.7

101.3

1.25

543

3691

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

453

2469

2.12

38.16

3.4

2.7

e6/l

0.9

1.3

1.17

216

1424

(3030467) Casts [#/volume] in Urine by Automated count

650

4053

1.95

37.49

3.9

3.1

e6/l

0.5

0.10

479

3087

(3018418) pH of Serum or Plasma

681

4395

1.89

34.78

4.0

3.9

7.4

0.51

838

(3013826) Glucose [Moles/volume] in Serum or Plasma

1130

8602

1.87

33.51

5.1

4.8

mmol/l

6.6

6.8

1.25

1079

8049

(3002582) Erythrocytes [#/volume] in Urine

676

4439

1.85

32.04

4.0

3.2

e6/l

104.1

79.9

0.18

504

3443

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

479

2813

1.96

32.03

4.6

3.7

ng/l

243.0

383.2

0.93

373

2188

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

922

6684

1.79

31.16

6.1

5.9

mmol/l

1.2

0.07

863

6034

(42870588) Differential panel, method unspecified - Blood

725

4937

1.79

29.95

6.1

5.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1324

10825

1.88

28.72

5.0

4.1

mm/h

12.5

0.02

1249

10010

(3031040) Bacteria [#/volume] in Urine by Automated count

1213

9685

1.80

28.06

5.7

4.5

e6/l

270.2

1994.8

1.78

149

(3024561) Albumin [Mass/volume] in Serum or Plasma

875

6373

1.74

27.98

4.7

4.8

g/l

35.9

35.4

1.83

806

5930

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

269

1362

2.15

26.55

2.7

2.3

u/l

36.4

41.0

0.28

233

1158

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

421

2500

1.90

26.54

1.4

1.3

iu/ml

24.4

31.1

0.75

133

794

(3014111) Lactate [Moles/volume] in Serum or Plasma

253

1259

2.18

26.07

5.8

7.2

mmol/l

1.2

1.4

2.36

241

1214

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1355

11292

1.85

25.96

8.0

7.5

u/l

76.5

78.2

0.73

1293

10619

(3013650) Neutrophils [#/volume] in Blood by Automated count

1081

8476

1.71

25.31

8.7

8.9

e9/l

4.2

4.1

0.80

914

7439

(3022096) Basophils/100 leukocytes in Blood

890

6634

1.69

25.15

6.6

5.8

0.7

0.43

849

6196

(3018010) Neutrophils/100 leukocytes in Blood

921

6937

1.68

24.94

6.6

5.7

56.8

57.6

1.25

880

6496

(3044640) Blood type and Crossmatch panel - Blood

673

4677

1.71

24.58

2.7

2.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

504

3235

1.78

24.39

1.9

1.7

mg/l

1.3

1.2

0.20

398

2492

(3002030) Lymphocytes/100 leukocytes in Blood

928

7029

1.67

24.38

6.7

5.9

27.9

27.5

0.45

884

6555

(3006504) Eosinophils/100 leukocytes in Blood

908

6839

1.67

24.37

6.6

5.8

2.9

2.8

0.93

863

6375

(3006315) Basophils [#/volume] in Blood

955

7296

1.67

24.20

6.5

5.6

e9/l

0.0

0.00

796

6325

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

832

6136

1.67

24.14

2.3

2.0

pmol/l

95.0

95.4

0.07

430

3193

(3019069) Monocytes/100 leukocytes in Blood

910

6869

1.67

24.13

6.8

6.1

8.7

8.6

0.22

871

6435

(3019198) Lymphocytes [#/volume] in Blood

971

7461

1.67

23.97

6.6

5.7

e9/l

1.9

0.03

829

6574

(3001604) Monocytes [#/volume] in Blood

950

7271

1.66

23.70

6.5

5.6

e9/l

0.6

1.15

793

6303

(3013115) Eosinophils [#/volume] in Blood

977

7544

1.66

23.44

6.7

5.9

e9/l

0.2

0.78

832

6638

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

170

747

2.41

23.42

6.5

10.1

mmol/l

24.1

24.4

0.74

160

703

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

957

7352

1.66

23.42

6.7

mmol/l

1.2

0.13

831

6180

(3037522) Nuclear Ab [Titer] in Serum

334

1912

1.92

23.22

1.4

1.3

titre

481.9

516.3

0.11

415

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

908

6898

1.65

23.09

4.2

4.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

394

2382

1.84

23.09

1.3

u/ml

11.7

12.1

0.03

113

931

(3001122) Ferritin [Mass/volume] in Serum or Plasma

850

6356

1.65

22.97

3.3

2.8

ug/l

109.3

127.1

2.12

786

5871

(3037467) Urinalysis macro (dipstick) panel - Urine

1232

10134

1.71

22.91

5.1

4.3

—

(3000991) Gas panel - Venous blood

233

1181

2.12

22.75

7.0

8.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

982

7662

1.63

22.02

5.5

6.1

umol/l

11.4

0.03

941

7272

(3011397) Hemoglobin [Presence] in Urine by Test strip

503

3311

1.73

21.88

3.7

3.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

380

2329

1.80

21.08

2.5

umol/l

12.8

13.1

0.38

351

2151

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

629

4447

1.64

20.61

2.5

2.2

u/l

312.3

227.9

0.50

601

4174

(3026782) Osmolality of Urine

450

2920

1.73

20.39

2.9

2.7

mosm/kgh2o

536.9

548.0

0.53

385

2483

(40758558) Short blood count panel - Blood

538

3688

1.66

19.73

6.6

6.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

523

3560

1.67

19.71

2.6

2.3

—

(3044889) 12 lead EKG panel

1232

10307

1.64

19.67

4.3

3.8

—

(40768797) Stomach Pathology biopsy report

342

2077

1.80

19.40

1.3

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

922

7234

1.57

19.03

3.9

3.7

estimate

0.0

1.08

148

1321

(3035350) Ketones [Presence] in Urine by Test strip

912

7140

1.57

18.98

3.8

3.7

estimate

0.0

0.00

148

1356

(3021601) Nitrite [Presence] in Urine by Test strip

913

7155

1.57

18.88

5.2

5.0

estimate

0.0

0.50

151

1363

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

332

2016

1.80

18.79

2.5

21.8

22.9

0.80

290

1718

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

543

3770

1.64

18.76

2.3

2.2

mg/l

2.7

3.0

2.14

451

3196

(3000850) Epithelial cells [#/volume] in Urine

468

3130

1.67

18.72

2.6

e6/l

6.1

6.0

0.03

416

2748

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1602

14511

2.09

18.68

19.9

14.4

mg/l

24.0

0.00

1364

11537

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

282

1653

1.84

17.86

2.7

2.5

umol/l

7.1

8.0

0.28

248

1439

(3004789) Transferrin [Mass/volume] in Serum or Plasma

343

2155

1.73

17.11

2.5

g/l

2.3

0.16

322

1999

(3003396) Base excess in Arterial blood by calculation

282

1682

1.80

16.80

6.0

7.6

mmol/l

0.3

1.2

4.31

226

1308

(3032080) INR in Blood by Coagulation assay

778

5990

1.53

16.69

9.0

9.8

inr

1.2

1.3

1.01

210

1735

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

281

1678

1.80

16.67

6.0

7.6

kpa

5.1

0.50

268

1600

(3027801) Oxygen [Partial pressure] in Arterial blood

281

1679

1.80

16.64

6.0

7.6

kpa

13.2

12.1

2.01

268

1601

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

372

2410

1.69

16.53

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

289

1746

1.78

16.47

2.1

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

503

3518

1.60

16.47

1.7

1.6

nmol/l

20.0

20.9

0.69

448

2984

(3021589) Normoblasts [#/volume] in Blood

820

6420

1.52

16.05

10.6

9.5

e9/l

0.0

0.58

632

5255

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

278

1677

1.78

15.89

1.8

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

414

2794

1.63

15.58

2.8

3.1

mmol/l

2.4

2.5

0.26

359

2469

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

278

1688

1.77

15.52

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

139

667

2.18

15.48

3.7

3.5

mmol/l

24.3

24.1

0.28

125

598

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1493

13400

1.73

15.40

5.5

4.8

mu/l

1.8

2.1

1.40

1388

12243

(3002385) Erythrocyte distribution width [Ratio]

1369

12041

1.60

15.04

24.8

17.5

13.8

13.7

0.21

1348

11778

(3015377) Calcium [Moles/volume] in Serum or Plasma

669

5073

1.51

14.93

3.0

3.4

mmol/l

2.4

0.39

597

4431

(3014007) Fractional oxyhemoglobin in Arterial blood

172

914

1.98

14.57

7.4

9.5

94.2

93.9

0.18

172

908

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1290

11233

1.55

14.40

4.3

4.1

pmol/l

14.7

14.8

0.80

1176

10217

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

167

882

1.99

14.40

1.7

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

427

2.40

14.18

2.5

g/l

0.2

0.0

0.96

392

(3012095) Magnesium [Moles/volume] in Serum or Plasma

363

2424

1.63

14.10

3.0

3.3

mmol/l

0.8

1.26

341

2277

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

170

919

1.94

13.69

7.5

9.3

1.2

1.3

0.79

170

911

(3042936) Bacteria identified in Isolate by Culture

324

2119

1.65

13.63

2.5

2.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

399

2.40

13.49

2.5

g/l

0.0

0.00

370

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1048

8801

1.47

13.47

3.1

2.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

392

2698

1.58

13.34

1.5

1.4

g/l

2.4

2.5

0.82

219

1634

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

168

913

1.93

13.32

7.5

9.4

0.6

0.7

0.59

168

906

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

404

2.37

13.13

2.5

g/l

0.0

0.00

371

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

105

481

2.26

13.11

2.5

2.7

g/l

0.6

1.2

1.03

425

(3019550) Sodium [Moles/volume] in Serum or Plasma

1616

14988

1.89

13.03

22.3

16.6

mmol/l

139.5

139.6

1.79

1593

14605

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

572

4294

1.49

12.98

3.1

3.0

ng/l

1573.1

1368.8

0.43

485

3672

(3026008) Bacteria identified in Urine by Culture

599

4543

1.48

12.90

3.7

3.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

764

6077

1.45

12.84

2.4

2.3

nmol/l

76.8

77.9

0.57

701

5432

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

620

4750

1.47

12.62

3.1

3.2

u/l

32.5

33.0

0.10

595

4521

(3023368) Bacteria identified in Blood by Culture

538

4011

1.49

12.55

4.9

4.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

148

790

1.95

12.36

6.9

10.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

518

3844

1.49

12.32

2.7

2.6

umol/l

883.7

6195.3

7.22

440

3327

(3023103) Potassium [Moles/volume] in Serum or Plasma

1616

15034

1.86

12.23

22.7

16.8

mmol/l

4.0

0.57

1593

14630

(3018677) aPTT in Platelet poor plasma by Coagulation assay

331

2239

1.59

12.01

2.3

2.0

29.9

29.7

0.19

324

2163

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

443

2.23

11.80

2.5

2.4

g/l

38.9

37.6

1.62

387

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

530

2.13

11.76

2.4

2.5

g/l

2.9

3.1

1.67

420

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1106

9507

1.44

11.72

3.3

3.1

u/l

45.4

49.7

1.44

1037

8859

(3002173) Hemoglobin [Mass/volume] in Arterial blood

225

1396

1.70

11.47

6.8

8.5

g/l

122.6

120.8

0.65

220

1344

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

563

2.08

11.44

2.3

2.5

g/l

3.8

0.03

412

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

564

2.07

11.39

2.3

2.5

g/l

7.3

7.4

0.39

430

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

564

2.07

11.39

2.3

2.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

304

2.46

11.33

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

304

2.46

11.33

1.2

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

439

2.21

11.23

4.1

3.3

—

(3048689) Calprotectin [Mass/mass] in Stool

259

1677

1.64

11.20

2.2

ug/g

137.8

123.0

0.20

215

1322

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

525

2.08

10.91

2.4

2.5

g/l

10.0

10.4

0.70

448

(3004588) Protein electrophoresis panel - Serum or Plasma

171

1008

1.77

10.44

2.3

2.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

512

3899

1.44

10.33

1.7

mmol/l

1.4

0.35

439

3266

(36660697) Celiac disease serology panel - Serum

182

1096

1.74

10.31

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

588

4598

1.42

10.22

2.8

2.5

u/l

54.9

56.9

0.33

539

4241

(3009542) Hematocrit [Volume Fraction] of Blood

1443

13177

1.51

10.19

23.1

15.5

39.9

39.6

1.00

1065

9312

(3000492) Spirometry study

214

1356

1.66

10.04

1.6

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1466

13443

1.53

10.03

6.2

5.8

mmol/mol

39.6

39.9

0.91

1382

12424

(3003338) MCHC [Mass/volume]

1349

12169

1.46

10.00

25.9

18.6

g/l

331.8

332.1

0.61

1339

12077

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

294

2.37

9.76

2.2

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

194

1211

1.68

9.63

2.3

2.8

g/l

67.4

66.6

0.86

178

1108

(3024928) Oxygen saturation in Venous blood

311

2.30

9.46

3.2

2.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

418

3110

1.45

9.42

1.3

1.2

u/ml

2.1

1.5

0.23

816

(3021447) Carbon dioxide [Partial pressure] in Venous blood

208

1330

1.64

9.40

3.7

3.5

kpa

5.9

5.8

0.83

198

1289

(3002032) Base excess in Venous blood by calculation

207

1328

1.63

9.23

3.7

3.5

mmol/l

1.6

1.9

0.54

168

1047

(3019309) Folate [Moles/volume] in Red Blood Cells

383

2818

1.46

9.12

1.7

1.8

nmol/l

1096.1

1185.7

1.16

287

2126

(3015171) Extractable nuclear Ab [Units/volume] in Serum

104

550

1.95

8.96

1.3

u/ml

0.2

0.8

—

(3036489) Thrombin time

102

537

1.95

8.90

2.2

1.9

22.7

21.5

0.40

471

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

8.05

8.86

1.6

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

196

1254

1.63

8.83

2.3

2.9

ng/l

146.5

206.1

2.03

180

1140

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

320

2303

1.48

8.49

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

717

5942

1.35

8.28

2.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1482

13755

1.47

8.22

18.7

13.3

ml/min/173m2

80.3

80.0

0.25

1271

11329

(3003327) Ova and parasites identified in Stool by Light microscopy

432

1.99

7.87

1.6

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1513

14130

1.49

7.83

5.0

4.6

mmol/l

5.9

6.0

0.73

1378

12829

(3027945) Reticulocytes/100 erythrocytes in Blood

240

1654

1.52

7.83

2.4

2.6

1.9

1.8

0.24

209

1471

(3021788) Differential panel - Synovial fluid

278

2.24

7.81

1.7

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

148

2.67

7.41

4.2

3.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

273

1962

1.46

7.23

5.3

5.5

mmol/l

1.0

0.60

251

1808

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1624

15453

1.61

7.14

12.7

10.4

u/l

26.6

25.8

0.71

1585

14916

(3034274) Bile acid [Moles/volume] in Serum --fasting

131

2.71

6.85

1.4

2.1

umol/l

11.3

6.2

0.58

(40761511) CBC panel - Blood by Automated count

1590

15083

1.53

6.78

16.6

13.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

139

873

1.64

6.75

3.5

3.4

pmol/l

4.4

4.5

0.87

127

761

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

233

1650

1.47

6.63

3.9

4.1

u/l

231.6

249.3

1.32

220

1560

(3028026) IgM [Mass/volume] in Serum or Plasma

136

854

1.64

6.61

1.9

1.7

g/l

1.9

1.4

0.45

126

788

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

438

1.89

6.60

2.4

2.0

93.9

90.7

0.65

410

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

286

2.10

6.53

1.2

u/ml

55.3

43.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

392

1.93

6.42

1.2

—

38.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

304

2279

1.40

6.35

1.6

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

224

1590

1.47

6.30

3.9

3.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

103

609

1.73

6.28

1.3

1.5

—

11.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

198

1372

1.50

6.27

2.1

nmol/l

368.5

372.8

0.13

180

1252

(3024354) Oxygen [Partial pressure] in Venous blood

165

1100

1.55

6.26

3.0

2.8

kpa

4.5

4.6

0.29

153

1063

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

667

5631

1.30

6.26

4.4

3.7

ng/l

37.7

47.6

0.41

459

3897

(1002224) Polysomnography panel

101

595

1.74

6.24

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

444

1.84

6.04

3.0

3.7

mg/l

745.1

64.7

0.47

366

(3022145) Colonoscopy Study observation

229

1646

1.45

6.03

1.4

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

6.28

5.96

1.1

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

447

1.83

5.91

2.9

3.7

mg/l

27.0

55.1

1.33

370

(3039162) Centromere protein B Ab [Units/volume] in Serum

168

2.35

5.76

1.1

1.3

—

50.1

—

(4010399)

154

1034

1.54

5.67

1.4

—

(3044941) Cell count panel - Synovial fluid

237

2.10

5.50

1.6

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

451

1.79

5.47

1.6

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

104

645

1.65

5.35

1.6

2.0

u/l

38.1

39.3

0.23

570

(3023520) Reticulocytes [#/volume] in Blood

175

1229

1.47

5.20

2.3

2.7

e9/l

75.8

71.4

0.73

103

947

(40768443) Skin Pathology biopsy report

101

627

1.65

5.19

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

110

698

1.61

5.18

1.9

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

157

1082

1.49

5.13

2.4

2.7

g/l

10.0

10.8

1.72

149

994

(3024869) Neuronal Ab [Presence] in Serum

4.47

5.04

1.3

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

250

1897

1.37

4.81

23.5

25.8

inr

1.4

0.04

256

(3000570) Elastase.pancreatic [Mass/mass] in Stool

441

1.73

4.73

1.5

ug/g

242.7

277.0

0.78

253

(3008898) HLA-B27 [Presence]

495

1.69

4.71

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.73

4.68

1.9

2.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

103

661

1.59

4.66

1.7

1.8

g/l

1.5

0.41

573

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

153

1073

1.47

4.60

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1536

14663

1.36

4.55

5.4

4.9

mmol/l

2.7

1.30

1421

13457

(3026470) Cobalt [Mass/volume] in Blood

2.67

4.49

1.8

2.0

ug/l

2.5

3.3

0.39

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

127

862

1.51

4.49

1.6

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

102

663

1.57

4.38

3.1

2.5

0.6

0.7

1.20

639

(3009508) Creatinine [Moles/volume] in Urine

536

4566

1.25

4.32

2.9

3.2

mmol/l

7.4

0.01

440

3832

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

220

1666

1.37

4.29

1.8

1.9

1.5

0.02

188

1455

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

247

1909

1.34

4.22

1.5

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.43

4.18

1.1

100.4

87.0

—

(3007461) Platelets [#/volume] in Blood

1659

16083

1.50

4.17

28.8

21.3

e9/l

251.3

250.6

0.17

1622

15672

(3024731) MCV [Entitic volume]

1659

16088

1.49

4.11

28.7

21.2

91.5

91.2

2.59

1642

15848

(3035941) MCH [Entitic mass]

1659

16090

1.49

4.08

28.7

21.2

30.4

30.3

1.28

1642

15848

(3026361) Erythrocytes [#/volume] in Blood

1659

16091

1.49

4.07

28.8

21.3

e12/l

4.4

4.5

1.79

1621

15641

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

142

2.20

4.06

3.3

3.8

—

(3025577) Chromium [Mass/volume] in Blood

2.58

4.05

1.8

2.0

ug/l

1.8

2.1

0.24

(3010813) Leukocytes [#/volume] in Blood

1659

16094

1.49

4.03

28.9

21.3

e9/l

6.8

6.7

1.84

1621

15643

(3000963) Hemoglobin [Mass/volume] in Blood

1659

16094

1.49

4.03

29.0

21.4

g/l

133.8

134.6

1.62

1642

15851

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.77

4.02

2.6

u/ml

838.4

1485.3

0.86

(3000475) Leukocytes [#/volume] in Synovial fluid

359

1.72

3.89

1.8

1.7

e6/l

6571.2

13839.8

1.31

269

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

7.30

3.86

2.0

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

157

1146

1.41

3.83

3.7

ng/l

84.4

90.3

0.45

141

993

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

540

1.58

3.82

1.8

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

250

1.86

3.82

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

3.20

3.78

1.0

2.9

159.1

160.7

0.02

(3017143) Hepatitis C virus Ab [Presence] in Serum

199

1516

1.35

3.75

1.5

1.6

—

(3000494) Fungus identified in Specimen by Culture

224

1738

1.33

3.73

1.6

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.02

3.70

1.0

1.1

84.7

102.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.02

3.70

1.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

483

1.60

3.64

3.5

2.6

u/ml

0.4

0.06

280

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

405

1.65

3.63

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

170

2.02

3.60

1.6

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

205

1579

1.34

3.59

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1501

14379

1.29

3.58

4.6

4.4

mmol/l

4.6

4.7

2.17

1394

13283

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.66

3.56

1.3

1.2

2.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

126

899

1.43

3.51

1.3

u/ml

139.4

209.7

1.09

114

820

(3021879) Hepatitis B virus core Ab [Presence] in Serum

134

969

1.41

3.47

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

172

1297

1.36

3.47

7.8

7.5

mmol/l

9.6

10.0

0.34

164

1237

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.55

3.46

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.55

3.46

1.1

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

216

1.87

3.42

1.2

1.7

g/l

0.6

0.9

0.81

164

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

413

1.62

3.39

1.9

2.1

mg/l

11.2

11.8

0.31

379

(3024891) Influenza virus A+B Ag [Presence] in Specimen

382

1.65

3.38

1.2

—

(3023410) Appearance of Cerebral spinal fluid

147

2.06

3.37

1.6

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

154

2.03

3.36

1.3

1.2

u/l

62.9

54.6

0.64

110

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

2.43

3.31

1.3

1.0

iu/ml

7.6

10.2

—

(3006653) Thiamine [Moles/volume] in Blood

2.43

3.31

1.4

1.3

nmol/l

134.9

141.3

0.30

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

371

1.64

3.24

1.4

1.3

—

(4306422)

213

1.85

3.23

1.2

—

(3012516) Albumin [Mass/volume] in Urine

499

4331

1.21

3.22

3.0

3.3

mg/l

433.6

344.4

0.16

310

2748

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

236

1.80

3.19

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

312

1.69

3.15

1.6

2.2

g/l

131.5

130.3

0.09

234

(40760888) Immunoglobulin light chains.free panel - Serum

330

1.66

3.07

2.2

3.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.45

3.05

1.7

1.2

—

(4034850)

457

1.55

3.04

12.5

10.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

324

1.66

3.01

1.3

1.4

e6/l

6.8

37.0

0.95

255

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

324

1.66

3.01

1.4

1.5

e6/l

890.3

764.5

0.08

268

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

10.02

2.98

11.6

13.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

235

1.76

2.94

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

101

2.19

2.93

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

101

2.19

2.93

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

101

2.19

2.93

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

486

1.52

2.92

1.6

1.5

titre

80.0

178.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

128

950

1.37

2.89

1.2

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

163

1257

1.33

2.87

2.5

ug/l

10.4

7.0

0.55

140

1116

(3019832) Treponema pallidum Ab [Presence] in Serum

145

1102

1.34

2.82

1.4

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

103

2.15

2.81

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

103

2.15

2.81

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

103

2.15

2.81

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

520

4581

1.19

2.80

3.6

4.0

mg/mmol

11.3

8.9

0.44

309

2880

(3051651) Icteric interference index of Serum or Plasma

2.24

2.80

5.4

3.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.56

2.79

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.32

2.75

1.1

1.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

179

1409

1.30

2.73

2.4

2.1

g/l

0.2

1.97

165

1319

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

196

1.80

2.73

1.2

1.0

u/ml

1.0

2.7

1.98

(3011985) Renin [Units/volume] in Plasma

167

1.87

2.72

1.2

1.4

mu/l

63.0

52.1

0.11

149

(3028192) IgG subclass 2 [Mass/volume] in Serum

125

2.01

2.71

1.2

1.4

g/l

2.6

2.8

0.22

(3027135) IgG subclass 1 [Mass/volume] in Serum

125

2.01

2.71

1.2

1.4

g/l

6.0

7.1

0.93

(3024139) IgG subclass 3 [Mass/volume] in Serum

125

2.01

2.71

1.2

1.4

g/l

0.4

0.01

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

446

1.52

2.70

1.4

1.6

iu/ml

0.0

15.1

0.50

(3030313) Adrenal Ab [Titer] in Serum

6.02

2.70

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

382

1.56

2.69

1.6

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

133

1.97

2.65

1.5

1.3

28.2

32.9

0.27

(1761868) Lipid panel - Serum or Plasma

448

5094

0.84

2.65

3.0

2.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

392

1.55

2.64

1.1

1.2

—

(3011648) Oxygen content in Venous blood

113

2.05

2.62

2.4

1.8

9.9

10.9

0.48

113

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

410

1.53

2.59

1.9

2.1

u/l

4829.4

3699.9

0.12

156

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

222

1.73

2.58

1.4

1.2

u/ml

7.5

2.9

0.56

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

518

1.47

2.55

2.3

2.2

ug/l

620.9

439.4

0.31

483

(3016018) Differential panel - Cerebral spinal fluid

150

1.88

2.52

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

398

1.53

2.48

1.2

1.1

u/ml

5.0

7.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1479

14275

1.22

2.48

4.6

4.4

mmol/l

1.4

1.5

1.81

1366

13102

(3003888) Timothy IgE Ab [Units/volume] in Serum

195

1.76

2.47

1.2

1.1

u/ml

2.2

5.6

1.29

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

432

1.50

2.45

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.56

2.44

1.0

1.1

—

(3019060) Gas panel - Arterial blood

129

987

1.33

2.43

3.9

4.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

144

1826

0.77

2.37

4.8

4.5

33.0

32.5

0.25

107

1239

(3029396) Erythrocyte agglutination [Presence] in Blood

3.65

2.36

3.4

3.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

436

1.49

2.35

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.05

2.32

2.5

2.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

255

1.62

2.25

1.7

1.2

—

(3019150) Specific gravity of Urine by Refractometry

362

3148

1.19

2.22

4.5

4.0

kg/l

1.0

0.18

466

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

370

3225

1.19

2.21

1.7

pmol/l

14915688.6

31083037.9

0.44

295

2651

(3028707) Methadone [Presence] in Urine by Screen method

172

1.76

2.21

1.7

2.2

—

(40761536) Microorganisms panel - Urine sediment

159

1270

1.28

2.20

4.1

3.8

—

(3029937) Albumin [Presence] in Urine by Test strip

437

3866

1.17

2.19

4.7

4.0

estimate

0.0

1.08

147

1319

(3002256) Pathology report gross observation

228

1901

1.23

2.18

1.4

1.3

—

(4062490)

129

1.87

2.17

1.2

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

162

1300

1.27

2.16

1.8

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

219

1.66

2.16

1.4

1.2

u/ml

5.0

5.5

0.08

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

108

1.96

2.15

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

146

1160

1.28

2.12

1.5

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

175

1.73

2.10

1.1

1.3

nmol/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

138

1.82

2.09

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

441

1.44

2.05

1.2

—

(3014891) Appearance of Pleural fluid

3.51

2.05

1.3

1.5

—

(3047181) Lactate [Moles/volume] in Blood

476

1.42

2.02

3.5

6.4

mmol/l

1.2

1.3

0.53

414

(3041096) Erythrocytes [Presence] in Urine by Automated

441

3928

1.16

2.02

3.5

3.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.51

2.01

1.2

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

296

1.53

1.99

1.3

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

607

5539

1.15

1.98

4.2

3.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

102

780

1.33

1.97

2.5

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

145

1164

1.27

1.95

1.7

1.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.36

1.95

1.6

1.3

g/l

39.8

37.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

363

1.47

1.94

2.2

1.8

iu/l

2.8

5.0

2.43

128

(3006462) Nitrate [Presence] in Urine

2.25

1.91

3.2

3.4

—

(3019225) pH of Specimen

118

1489

0.78

1.91

4.4

—

(3012501) Base excess in Blood by calculation

332

1.49

1.90

3.3

4.7

mmol/l

2.2

2.7

0.88

229

(3005011) Chlamydia sp Ab [Titer] in Serum

3.19

1.88

1.6

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

237

1.57

1.85

1.6

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

152

1.72

1.83

2.3

2.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1204

0.76

1.83

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

175

1.67

1.83

1.1

1.3

—

(3045142) Bone marrow Pathology biopsy report

160

1.70

1.82

1.1

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

145

1.73

1.81

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

419

1.42

1.81

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

521

1.38

1.81

1.8

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.96

1.80

1.3

1.1

ratio

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

3.05

1.80

1.3

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

462

0.62

1.79

1.3

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.45

1.75

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

585

1.35

1.75

2.6

2.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

120

956

1.27

1.74

1.2

iu/ml

86.1

149.6

1.36

372

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.34

1.74

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

314

1.48

1.74

1.6

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

249

1.54

1.74

1.3

1.2

u/ml

243.8

276.1

0.39

149

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

103

1.85

1.72

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.14

1.71

1.1

iu/ml

116.5

224.3

1.12

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.85

1.71

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

187

1.61

1.69

1.2

1.1

u/ml

1.5

2.3

0.25

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

219

1.56

1.68

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

493

4483

1.14

1.66

4.8

5.0

ug/l

2.2

2.8

1.09

442

4011

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.16

1.66

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.16

1.66

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

2.59

1.66

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

221

1.55

1.63

1.3

1.1

u/ml

0.4

2.4

1.48

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

489

1.36

1.62

1.2

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

498

1.36

1.61

2.2

2.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

128

1.73

1.60

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.91

1.60

1.1

2.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.70

1.58

3.1

1.9

umol/l

18.9

16.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.70

1.58

1.4

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

424

1.38

1.55

2.2

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

241

1.50

1.53

1.0

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

118

956

1.25

1.52

2.5

2.2

nmol/l

11.9

12.5

0.31

100

839

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

260

2273

1.17

1.52

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

185

1.58

1.51

1.7

1.5

57.8

61.1

0.16

113

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.60

1.51

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

375

1.40

1.51

1.3

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

162

1.61

1.49

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

218

1.52

1.49

1.1

—

(1616796) Gas panel - Central venous blood

317

1.43

1.49

3.0

3.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.82

1.47

1.2

1.3

—

63.1

—

(3025159) Blasts/100 leukocytes in Blood

133

1099

1.23

1.45

3.9

4.1

0.0

0.4

0.71

277

(3037756) Immunofixation for Serum or Plasma

336

1.41

1.44

1.6

—

(3003181) Sodium [Moles/volume] in Urine

261

1.47

1.44

1.2

1.3

mmol/l

64.9

62.4

0.12

215

(4211845)

1.98

1.43

3.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.86

1.40

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.20

1.37

1.1

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.95

1.36

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.95

1.36

1.2

1.5

umol/l

48.2

47.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.76

1.35

1.6

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

265

1.44

1.35

1.4

—

(3024263) Appearance of Synovial fluid

1.87

1.34

1.9

1.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.13

1.33

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

800

1.25

1.33

1.2

—

(3020891) Body temperature

577

1.29

1.33

5.1

4.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

0.00

1.32

0.0

1.2

—

23.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.74

1.31

1.2

1.4

—

370.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

605

1.29

1.31

1.4

1.3

iu/l

27.8

28.8

0.11

519

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

267

1.43

1.30

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

114

939

1.23

1.30

7.1

mmol/l

24.2

24.6

0.69

106

876

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.36

1.29

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.36

1.29

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.36

1.29

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.36

1.29

1.0

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1.77

1.29

1.1

1.9

13.1

14.0

0.13

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

235

1.46

1.27

1.2

1.4

u/ml

95.0

126.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

227

1.46

1.27

1.3

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.29

1.27

1.0

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

139

1174

1.20

1.24

3.1

2.6

ml/min/173m2

67.6

65.7

0.24

490

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

394

3597

1.12

1.24

4.1

4.3

23.2

21.4

1.24

171

1734

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.97

1.22

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.64

1.21

23.8

9.0

mmol/l

6.7

6.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.64

1.21

1.2

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.17

1.21

1.1

—

(3015183) Erythrocyte sedimentation rate

1.84

1.19

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

222

1.45

1.19

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.31

1.18

2.3

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

165

1.52

1.18

1.4

1.8

—

(4027681)

1.73

1.15

1.3

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

608

1.26

1.15

1.7

1.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

138

1176

1.19

1.14

3.9

4.0

0.3

0.1

0.47

329

(3004716) Salmonella sp identified in Stool by Organism specific culture

728

1.23

1.11

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.97

1.11

3.1

2.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.73

1.09

1.4

1.3

ug/l

9.1

7.6

0.17

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.76

1.06

2.5

2.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

132

1131

1.18

1.04

3.3

3.8

0.5

0.6

0.20

260

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.06

1.03

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

122

1.56

1.02

1.1

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.89

1.01

1.8

1.6

pmol/l

16.0

14.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

108

0.46

1.01

1.4

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.65

1.00

1.1

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.65

1.00

1.1

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

1.77

1.00

6.8

14.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.62

1.00

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

156

1.48

0.98

1.2

1.4

mosm/kgh2o

272.5

279.1

0.56

115

(3017181) Myelocytes/100 leukocytes in Blood

143

1245

1.16

0.94

3.9

4.0

1.4

0.9

0.37

360

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

116

0.52

0.94

1.3

1.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.62

0.94

1.2

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.82

0.92

2.8

1.9

ug/l

20.4

167.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1408

13791

1.10

0.92

4.1

3.9

mmol/l

1.3

1.54

1280

12566

(1761482) Bacteria [#/volume] in Urine by Culture

395

0.73

0.91

3.8

4.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.15

0.91

1.5

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

555

1.23

0.91

1.6

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

323

1.31

0.90

3.1

2.9

umol/l

28.6

35.5

1.63

269

(3050129) First trimester maternal screen panel - Serum or Plasma

323

1.31

0.90

1.2

1.4

—

(3011288) Drugs identified in Urine by Screen method

263

1.34

0.88

2.8

2.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

286

2618

1.11

0.88

3.2

3.0

ug/l

0.8

0.12

213

1717

(3000012) Reticulocyte production index

1.65

0.88

1.3

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.79

0.88

1.5

1.9

—

(40767503) Oxygen content in Capillary blood by calculation

307

1.31

0.87

2.7

2.4

16.3

16.2

0.02

151

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

144

1.46

0.87

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

178

1.41

0.86

1.2

1.0

u/ml

1.2

4.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

273

1.33

0.86

1.2

1.4

—

17.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

159

1791

0.88

0.85

10.3

7.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

187

1.40

0.85

1.4

1.7

—

(3047189) Immunofixation for 24 hour Urine

1.67

0.85

2.3

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

533

1.23

0.84

2.8

3.5

u/ml

1531.2

7509.4

0.60

459

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.94

0.84

1.5

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.76

0.83

2.8

4.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

363

1.27

0.83

1.3

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

241

1.33

0.81

1.9

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.71

0.80

1.4

2.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

285

1.30

0.80

1.8

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.82

0.79

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.82

0.79

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.63

0.78

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

208

1.35

0.77

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

186

0.64

0.77

2.3

2.6

—

(3025130) Human papilloma virus identified in Specimen

174

1.38

0.77

1.3

1.8

—

(3005033) Fetal Nuchal fold Thickness US

226

1.33

0.76

1.4

—

(4268621)

149

1.41

0.75

2.7

2.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

185

0.65

0.75

1.3

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

289

1.29

0.74

4.2

5.2

iu/ml

885.6

325.4

—

(3005570) Glucose [Moles/volume] in Urine

160

0.62

0.73

1.5

2.2

—

(44790048)

167

1.38

0.73

1.5

1.6

—

(44790047)

167

1.38

0.73

1.5

1.6

—

(44806118)

167

1.38

0.73

1.5

1.6

—

(44790049)

167

1.38

0.73

1.5

1.6

—

(3000330) Specific gravity of Urine by Test strip

752

0.83

0.73

3.6

3.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

691

1.18

0.73

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

228

1.32

0.73

1.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.00

0.72

1.6

1.0

mg/g

6.9

6.8

—

(3011412) CD3 cells [#/volume] in Blood

125

1.44

0.72

1.6

2.0

e9/l

1.3

1.1

0.33

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

106

0.56

0.72

1.8

1.5

g/l

0.8

1.0

—

106

(3005988) Vibrio sp identified in Specimen by Organism specific culture

183

0.65

0.72

1.3

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

255

1.30

0.72

2.3

2.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

354

1.25

0.70

1.4

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

182

0.66

0.70

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

182

0.66

0.70

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

182

0.66

0.70

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.93

0.70

1.0

1.7

—

(3002619) Bacteria identified in Specimen by Culture

1.93

0.70

1.4

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

212

1.33

0.70

1.5

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

813

0.84

0.70

1.4

—

(3004451) EKG impression Narrative

1.56

0.68

1.4

1.2

—

(4198724)

1.67

0.68

1.4

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.60

0.68

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

170

1.36

0.67

1.7

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.79

0.66

1.0

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

342

3209

1.08

0.64

4.9

4.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

234

1.29

0.63

1.5

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1.52

0.62

11.3

11.8

mmol/l

0.6

0.44

(3013512) EKG study

454

4314

1.07

0.61

4.0

3.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.60

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.60

0.0

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

221

0.72

0.60

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

414

3925

1.07

0.60

1.5

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.50

0.59

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.2

—

175.7

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.59

0.0

6.7

—

(3044927) Protein electrophoresis panel - Urine

166

1.33

0.58

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

0.58

0.0

1.3

—

(3017732) Neutrophils [#/volume] in Blood

112

1000

1.13

0.58

2.7

3.0

e9/l

4.1

0.06

774

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

185

0.70

0.58

1.3

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

219

0.73

0.57

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

328

1.22

0.57

3.0

3.3

nmol/l

0.8

0.9

0.50

256

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

158

1.33

0.57

1.2

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

320

1.22

0.56

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

124

1.37

0.55

1.2

1.7

—

(40768793) Breast Pathology biopsy report

362

0.80

0.55

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

177

1.30

0.54

1.0

1.1

—

(4015189)

1.58

0.54

2.5

2.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

873

1.13

0.54

3.3

3.7

mmol/l

2.0

1.9

0.11

658

(3014271) Vancomycin [Susceptibility]

1.49

0.53

3.8

2.9

—

(3009343) pH of Capillary blood

102

912

1.13

0.53

3.4

3.7

7.4

0.00

114

(1617658) Protocol used for examination of sentinel lymph nodes

135

0.66

0.51

1.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

260

1.24

0.51

1.4

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

144

1.32

0.50

1.3

1.8

—

(3037121) Protein [Mass/volume] in Urine

530

0.85

0.50

2.8

3.3

g/l

0.2

0.3

1.27

212

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

408

1.18

0.50

1.2

1.3

miu/ml

117.8

225.2

1.31

186

(3009214) Lutropin [Units/volume] in Serum or Plasma

353

1.19

0.49

1.2

1.3

u/l

13.9

10.6

0.69

277

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.43

0.49

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

367

0.81

0.49

2.0

2.4

ug/min

90.2

106.3

0.15

227

(3016879) Cocaine [Presence] in Urine

363

1.19

0.48

1.6

2.0

—

(3017704) Immunofixation for Urine

1.40

0.48

1.1

1.8

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.46

0.46

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.39

0.46

1.9

1.6

u/l

5.3

8.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.60

0.45

1.6

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.43

0.45

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.43

0.45

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.40

0.45

1.1

1.2

—

(3023419) Bacteria identified in Sputum by Culture

201

1.25

0.45

1.3

2.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

102

925

1.11

0.44

3.5

3.6

kpa

5.2

0.16

862

(4094501)

395

1.17

0.44

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

452

1.15

0.43

5.2

4.0

mmol/l

4.0

3.9

0.77

419

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.61

0.43

1.2

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.61

0.43

1.4

1.3

—

(3045414) Leukocytes [Presence] in Urine

651

1.13

0.42

2.1

1.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.56

0.42

1.4

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

454

1.15

0.41

1.7

1.6

mu/l

278.2

304.6

0.43

411

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

132

1219

1.09

0.40

2.9

3.7

mmol/l

1.2

0.50

108

1050

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.40

0.0

1.6

—

7.7

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.40

0.0

1.2

—

27.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

568

1.13

0.40

3.7

4.1

mmol/l

25.3

25.0

0.38

530

(4133840)

1.47

0.40

1.4

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.40

0.0

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.43

0.39

1.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

259

0.81

0.39

1.4

1.7

—

(21494755) Public health laboratory ask at order entry panel

113

1228

0.91

0.39

1.3

1.4

—

(3019174) dRVVT (LA screen)

0.00

0.39

0.0

1.2

—

(3045788) Cell count panel - Pleural fluid

142

1.27

0.38

1.6

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.33

0.37

1.0

ng/l

238.9

319.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

479

1.13

0.36

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

479

1.13

0.36

1.4

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.34

0.35

1.0

1.1

u/l

0.9

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.65

0.35

4.8

3.5

—

(3024471) HLA-A [Type]

1.43

0.35

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.32

0.35

1.0

ng/l

759.3

676.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.32

0.35

1.0

ng/l

27.9

46.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

135

1.26

0.35

5.1

5.0

u/ml

203.8

43.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

117

1.28

0.35

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

1.34

0.34

1.6

2.0

—

45.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

118

1.27

0.33

1.0

1.2

—

(4146454)

155

0.77

0.33

3.2

2.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

378

1.14

0.33

3.0

2.9

mmol/l

24.2

25.1

0.63

327

(3033799) Differential panel - Peritoneal fluid

1.31

0.33

1.2

2.2

—

(3034426) Prothrombin time (PT)

1.28

0.32

1.8

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.28

0.32

1.3

1.4

—

(3012441) Differential panel - Pleural fluid

146

1.24

0.32

1.6

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

212

1.18

0.30

1.5

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

120

1.25

0.30

1.2

1.1

—

83.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.31

0.30

8.1

7.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

306

1.15

0.30

1.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.23

0.29

46.6

28.1

ug/l

8.1

7.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.23

0.29

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

130

1.23

0.28

1.4

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.27

0.27

1.0

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

338

1.13

0.26

2.8

2.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

150

1.20

0.26

1.2

1.4

e6/l

7671.2

95497.0

—

(3027944) Amphetamines [Presence] in Urine

386

1.12

0.26

1.7

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

141

1.21

0.26

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.25

0.25

1.2

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

387

1.11

0.25

1.6

1.9

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

273

1.14

0.25

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

273

1.14

0.25

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

105

1.24

0.24

2.1

1.7

nmol/l

19.7

18.5

0.24

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

148

0.81

0.24

1.5

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.27

0.24

1.4

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.17

0.24

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

274

1.13

0.24

1.4

—

(3022621) pH of Urine by Test strip

103

970

1.07

0.23

3.4

3.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.32

0.23

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

275

1.13

0.23

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

134

1.20

0.23

2.4

—

(3024932) HLA-DR beta [Type]

1.22

0.22

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

391

1.10

0.22

1.6

1.9

—

(3021901) Oxygen saturation in Capillary blood

267

1.13

0.21

2.3

2.6

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

5.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

7.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

5.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

258

1.13

0.21

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.21

0.0

4.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.25

0.20

1.2

1.4

—

(3028300) Cannabinoids [Presence] in Urine

393

1.10

0.20

1.6

1.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.20

0.0

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

202

1.14

0.20

1.6

—

(3028433) Virus identified in Specimen by Culture

1.20

0.19

1.2

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

231

1.13

0.19

1.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

118

1.19

0.19

1.2

1.1

—

56.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.15

0.19

1.3

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

184

1.14

0.19

1.1

1.3

—

(21494434) Karyotype in Bone marrow

137

1.17

0.18

1.1

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

280

1.11

0.18

3.7

3.1

e9/l

4.1

4.2

0.19

280

(3042631) Mycobacterium sp identified in Specimen

204

1.13

0.18

2.2

2.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.17

0.17

1.0

1.2

—

0.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

291

1.10

0.17

1.6

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

148

1.15

0.17

1.3

2.9

64.7

53.5

1.98

101

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.14

0.16

1.0

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

206

1.12

0.16

1.3

1.2

—

(40761535) Cells panel - Urine sediment

128

1231

1.04

0.16

4.0

3.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.77

0.15

1.0

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.77

0.15

1.0

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.77

0.15

1.0

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.77

0.15

1.0

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

293

1.09

0.15

3.9

3.4

54.4

57.8

1.07

293

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.21

0.15

1.3

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.21

0.15

1.3

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.14

0.15

1.2

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.14

0.15

1.2

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

161

0.87

0.15

1.4

1.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

150

1.13

0.14

1.1

u/ml

1.1

5.4

—

(3004616) Nuclear Ab [Presence] in Serum

179

1.12

0.14

1.4

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

189

1.11

0.13

1.3

1.5

nmol/l

0.3

0.14

146

(3023199) Leukocytes [#/volume] in Pleural fluid

170

1.12

0.13

1.4

e6/l

2543.3

1646.6

0.46

114

(3022313) Gas panel - Capillary blood

667

1.05

0.13

4.0

3.8

—

(44813793)

1.17

0.13

1.0

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

541

1.06

0.12

4.9

3.9

mmol/l

1.8

1.4

1.00

530

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

394

0.94

0.11

1.5

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

231

1.08

0.10

1.5

—

(3044007) Cell count panel - Peritoneal fluid

1.14

0.10

1.4

2.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.06

0.09

1.0

2.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.05

0.08

1.0

1.1

miu/ml

1767.7

1741.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

548

1.04

0.08

1.6

mg/l

4.1

4.2

0.04

385

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.82

0.08

1.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.82

0.08

1.0

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.81

0.08

1.0

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.78

0.08

1.0

1.3

—

(40768795) Lymph node Pathology biopsy report

143

0.91

0.07

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.03

0.07

1.3

1.6

—

10.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.12

0.07

1.0

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

236

1.06

0.06

1.6

3.4

1.7

1.4

0.18

189

(3045424) Erythrocytes [Presence] in Urine

244

0.94

0.06

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

119

1.09

0.06

1.4

1.2

u/ml

0.0

0.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

131

0.92

0.05

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

131

0.92

0.05

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

131

0.92

0.05

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

139

1.08

0.05

2.5

3.2

mg/l

26.0

22.0

—

105

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

149

1.07

0.05

2.5

2.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

159

1.07

0.05

1.1

1.0

u/ml

3.5

3.4

—

(40768441) Liver Pathology biopsy report

110

0.91

0.05

1.7

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

157

1549

1.01

0.05

2.9

4.2

ug/l

7.0

21.4

1.62

129

1274

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

367

1.04

0.04

1.4

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

150

0.93

0.04

2.3

2.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

724

0.98

0.04

2.1

1.7

—

(4024509)

141

1.06

0.03

1.3

1.5

—

(40768806) Pleura Pathology biopsy report

151

1.06

0.03

1.4

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

201

1.05

0.03

1.6

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

108

0.93

0.03

1.1

—

(4281824)

158

0.95

0.02

1.1

—

(4035726)

130

1289

1.01

0.02

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

167

0.96

0.01

1.5

3.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

592

1.01

0.01

2.9

2.0

ug/l

1.0

1.8

0.75

520

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

116

0.95

0.00

1.3

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

146

0.96

0.00

1.8

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

205

1.02

0.00

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

121

0.99

0.00

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

141

0.99

0.00

1.4

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

114

0.96

0.00

1.2

1.4

mmol/l

1.8

2.0

2.03

107

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

272

0.99

0.00

4.3

3.7

u/ml

34.0

31.4

0.07

265

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.4

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

5.2

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.92

0.00

1.0

1.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

5.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.93

0.00

1.0

1.7

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

21.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

1.00

0.00

1.3

1.5

—

(40768800) Prostate Pathology biopsy report

280

1.00

0.00

1.1

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.89

0.00

2.4

2.9

umol/l

28.6

30.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.98

0.00

1.2

2.3

—

55726.6

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

110

1.00

0.00

1.3

1.1

—

2.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.89

0.00

1.2

1.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.98

0.00

1.2

1.6

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.94

0.00

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.94

0.00

1.2

1.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_BIOMECHLESIO and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_BIOMECHLESIO	1.163 [1.04, 1.3]	0.01
Birth year	0.991 [0.98, 1.0]	0.05

During the follow-up period (1.1.1998 — 31.12.2019), 583 out of 3050 females with M13_BIOMECHLESIO died.

Males

Parameter	HR [95% CI]	p-value
M13_BIOMECHLESIO	1.207 [1.07, 1.36]	0.002
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 596 out of 2252 males with M13_BIOMECHLESIO died.

Mortality risk

Mortality risk for people of age

years, who have M13_BIOMECHLESIO.

N-year risk	Females	Males
1	0.088%	0.179%
5	0.625%	1.357%
10	1.566%	3.251%
15	3.048%	6.271%
20	5.052%	10.661%

Relationships between endpoints

↥

Index endpoint: M13_BIOMECHLESIO – Biomechanical lesions, not elsewhere classified

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Biomechanical lesions, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints